Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Data Science Helps Assess the Safety of “Inactive” Ingredients in Drugs

Posted on April 23rd, 2019 by in Pharma R&D

Elsevier’s Maria Shkrob’s study takes an microscopic lens to the topic of how data mapping and analytics can exposure the “under the radar” effects and potential dangers of inactive ingredients in drugs.

(more…)

Are Drug-Drug Interactions Today’s Biggest Health Threat?

Posted on October 16th, 2018 by in Pharma R&D

The use of prescription medicines is sharply on the rise. Over the past decade, the number of adults taking over-the-counter medicines has sunk, while the number of prescription drug users has increased by more than 30 percent. (more…)

The Delicate Balance of Drug Risks vs. Benefits

Posted on October 16th, 2018 by in Pharma R&D

For many people, taking medication is a regular part of their daily routine, and these medicines are relied upon to treat disease and improve health.  The benefits of medicines are the helpful effects you get when you use them, such as the lowering blood pressure, curing infection, or relieving pain. (more…)

Big Data and Proactive Pharmacovigilance

Posted on September 20th, 2017 by in Pharmacovigilance

Traditionally thought of as a post-market process, pharmacovigilance is how pharmaceutical companies monitor and address any safety issues that arise once a drug becomes available commercially. However, some companies are now thinking ahead about these potential safety concerns with what is known as “proactive PV”. (more…)

  1. 1
  2. 2
  3. 3
  4. 4